Effect of prasugrel for stent implantation in patients with acute coronary syndrome

Effect of prasugrel for stent implantation in patients with acute coronary syndrome - Prasugrel fo ACS study (PACS Study)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015192

Enrollment

Registered

2014-10-17

Start date

2015-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

prasugrel clopidogrel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) >= 20 years old, male and female 2) patients with ACS 3) patients underwent stent implantation 4) written informed concent

Exclusion criteria

Exclusion criteria: 1) on going bleeding 2) drug allergy due to study drug 3) pregnancy 4) appropriate patients decided by the doctor

Design outcomes

Primary

Measure	Time frame
The relationship between aggregation of platelet(PRU) and bio-markers of myocardium.	—

Secondary

Measure	Time frame
1.The relationship between aggregation of platelet(PRU) and angioscopic findings 2.The relationship between aggregation of platelet(PRU) an genottpe of CYP2C19	—

Countries

Japan

Contacts

Public ContactTadateru Takayama

Nihon University Division of Cardiology, Department of Medicine

takayama.tadateru@nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026